3175 Hanover Street
Palo Alto, California

Starting a Life Science company can be tough. There are plenty of challenges to starting any type of Biomedical company: choosing the right form of entity; developing a IP portfolio, advisors and early-in employees; bootstrapping until your first investors appear, then lasting sources of capital; knowing how much R&D and developing smart strategies for marketing, selling and managing channels.

Come hear a panel of seasoned entrepreneurs and strategists tell you what they learned when starting, running or counseling Life Science startups. The panel will walk you through the creative steps and calculated risks you may have to consider taking to get your Biomedical startup off the ground especially when the odds are pitched heavily against you. The panel will touch upon how to navigate the regulatory maze, enforce decisions from an indecisive and reluctant FDA. It will address questions such as when VCs talk about "market conditions," what do they mean? And more; Strategy Development, Startup Management, Regulatory, Capital Investment, Legal Aspect….

The Panel:

• Rich Ferrari, Managing Director, De Novo Ventures
• Carl Simpson, Managing Director, Coronis Medical Ventures, LLC
• TBD
• TBD

Moderator: Frank F. Rahmani, Partner, Cooley Godward Kronish, LLP

See website for speaker bio’s.

Register on our website at http://www.svase.org/?q=node/1784.

WHEN: Thursday, November 20
6:00 - 7:00 pm: Networking and Business Showcase
7:00 - 8:15 pm: Round table panel discussion and Q/A
8:15 - 8:30 pm: Additional networking

PRE-REGISTERED RATES (All Rates Include Hors D’oeuvres):
Members - $20; Affiliates who advertise this event - $29; General Public - $49;
Business Showcase Exhibit Table – member rate: $149; non-member rate: $250 (Includes exhibit table and two tickets to the event.)

WALK-IN RATES: Add $10.00 to the listed price

This event is co-sponsored Cooley Godward Kronish LLP, http://www.cooley.com

Official Website: http://www.svase.org/?q=node/1784

Added by svaseinfo on November 4, 2008

Interested 2